Advertisement
Advertisement

NBTX

NBTX logo

Nanobiotix S.A. - ADR

20.82
USD
+2.38
+12.93%
Oct 31, 14:59 UTC -5
Closed
exchange

After-Market

21.28

+0.45
+2.17%

Nanobiotix S.A. - ADR Profile

About

NANOBIOTIX is a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases. NANOBIOTIX is based in CAMBRIDGE, Mass.

Info & Links

CEO

Dr. Laurent Levy

Headquarters

60 RUE DE WATTIGNIES
PARIS, I0 75012, FRANCE

Sector

Medical

Auditor

Share holders

--

Employees

108

Nanobiotix S.A. - ADR Statistics

Valuation Measures

Market Capitalization2

1.03B

Enterprise Value

993.12M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.70

52-Week Change

373.30%

S&P 500 52-Week Change

19.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

46.29M

% Held by Insiders

3.45%

% Held by Institutions

38.81%

Balance Sheet

Total Cash(mrq)

32.71M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement